Filing Details
- Accession Number:
- 0001008310-12-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-17 16:07:14
- Reporting Period:
- 2012-02-16
- Filing Date:
- 2012-02-17
- Accepted Time:
- 2012-02-17 16:07:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008310 | D Peter Meldrum | 320 Wakara Way Salt Lake City UT 84108 | President & C.e.o. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-16 | 4,684 | $12.64 | 185,605 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-16 | 4,684 | $23.52 | 180,921 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-02-16 | 5,592 | $12.64 | 186,513 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-16 | 5,592 | $23.52 | 180,921 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-02-16 | 10,000 | $8.68 | 190,921 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-16 | 10,000 | $23.83 | 180,921 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-16 | 20 | $23.78 | 180,901 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-02-17 | 10,000 | $8.68 | 190,901 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-17 | 10,000 | $24.00 | 180,901 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-16 | 10,000 | $0.00 | 10,000 | $8.68 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-17 | 10,000 | $0.00 | 10,000 | $8.68 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-16 | 4,684 | $0.00 | 4,684 | $12.64 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-16 | 5,592 | $0.00 | 5,592 | $12.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,000 | 2012-08-16 | No | 4 | M | Direct | |
| 50,000 | 2012-08-16 | No | 4 | M | Direct | |
| 5,592 | 2012-02-22 | No | 4 | M | Direct | |
| 0 | 2012-02-22 | No | 4 | M | Direct |
Footnotes
- The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
Billionaire Hedge Funds
